Company

Wavelength Pharmaceuticals Inc.

Wavelength Pharmaceuticals Inc. develops and provides pharmaceutical products and formulations from Petah Tikva, Israel.

About

Wavelength Pharmaceuticals Inc. develops and provides pharmaceutical products and formulations for healthcare providers, mainly in North America and Europe. Founded in 1987 in Petah Tikva, Israel, the company is at the Series C stage. It was formed following SK Capital's acquisition of Perrigo API Limited, completed in November 2017, and a Buyout round of USD 110 mn was completed in August 2017.

1Funding rounds

2Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in